Last reviewed · How we verify
NCT04237519: SFL
The StayFitLonger Study: an Innovative Computerized Home-based Training to Foster Independent Life at Home
NA trial testing SFL training in Cognitive Decline Prevention in Robust Older Adults in 120 participants. Completed in 1 August 2021.
1 July 2021
Quick facts
| Lead sponsor | University of Lausanne Hospitals |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 120 |
| Start date | 11 January 2019 |
| Primary completion | 1 July 2021 |
| Estimated completion | 1 August 2021 |
| Sites | 4 locations across Belgium, Canada, Switzerland |
Drugs / interventions tested
- SFL training
- Active controlled training
Conditions studied
- Cognitive Decline Prevention in Robust Older Adults — all drugs for Cognitive Decline Prevention in Robust Older Adults →
- Cognitive Decline Prevention in Pre-frail Older Adults — all drugs for Cognitive Decline Prevention in Pre-frail Older Adults →
- Physical Decline Prevention in Robust Older Adults — all drugs for Physical Decline Prevention in Robust Older Adults →
- Physical Decline Prevention in Pre-frail Older Adults — all drugs for Physical Decline Prevention in Pre-frail Older Adults →
Sponsor
University of Lausanne Hospitals
Who can join
Adults 60 to 100, any sex, with Cognitive Decline Prevention in Robust Older Adults or Cognitive Decline Prevention in Pre-frail Older Adults. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Multimodal training, including physical and cognitive activities, has been associated with a reduction in age-related physical and cognitive decline. Therefore, combining these activities into a home-based computerized training program may represent a powerful approach to foster independent life at home. The StayFitLonger study is a 6-month multi-site randomized controlled, double-blind trial, which tests the efficacy of a home-based computerized intervention that combines physical and cognitive exercises through virtual coaching to enhance motivation. In Switzerland, Canada and Belgium, a total of 128 older participants will be recruited and randomly assigned to one of two physical and cognitive home-based interventions for 6 months: StayFitLonger or active control training. The StayFitLonger intervention provides physical and cognitive training exercises, feedback and instructions through a virtual coach to optimize motivation. It also offers social and psycho-educational contents. Monthly supervision (home-visits and phone calls) will be provided during this 6-month intervention. Outcomes will be measured at baseline, and after 6 months of training. This study will demonstrate the feasibility, sustainability and efficacy of a home-based multi-domain intervention program allowing further development and possible commercialization of a scientifically validated training program to slow down cognitive and physical decline.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Pre-frail older adults show improved cognition with StayFitLonger computerized home-based training: a randomized controlled trial.
Belleville S, Cuesta M, Bieler-Aeschlimann M, Giacomino K, et al · · 2023 · cited 18× · PMID 36266559 · DOI 10.1007/s11357-022-00674-5 -
Rationale and protocol of the StayFitLonger study: a multicentre trial to measure efficacy and adherence of a home-based computerised multidomain intervention in healthy older adults.
Belleville S, Cuesta M, Bieler-Aeschlimann M, Giacomino K, et al · · 2020 · cited 7× · PMID 32859156 · DOI 10.1186/s12877-020-01709-2
Verify or expand the search:
- PubMed search for NCT04237519
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Lausanne Hospitals trials
Trials by the same sponsor.
- NCT06912906 — Feasibility Study to Compare Two Ventilatory Modes for Mechanical Ventilation Weaning · NA · not yet recruiting
- NCT06482489 — Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM) · recruiting
- NCT06552832 — CAVEAT: An Open-Trial Feasibility Study · NA · recruiting
- NCT05927324 — Clinician-Assisted Videofeedback Exposure-Approach Therapy (CAVEAT) Trial · NA · recruiting
- NCT06320457 — A Brief Case Management Intervention for People Involuntarily Admitted to a Psychiatric Hospital · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04237519 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Lausanne Hospitals
- Last refreshed: 18 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04237519.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing